Can engineered immune cells tame autoimmune diseases?
Disease control
Not yet recruiting
This trial is testing an experimental therapy called CTA313, which uses engineered immune cells (CAR T cells) to potentially reset the immune system in people with active autoimmune diseases. The study will include adults aged 18 to 75 with systemic lupus erythematosus, progressi…
Phase 1 • Sponsor: Imviva Bio • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC